Congenital hypothyroidism: From paracelsus to molecular diagnosis

Clinical Biochemistry

Volumn 39, Issue 5, 2006, Pages 511-518

  Djemli, Anissa ^a   Van Vliet, Guy ^b   Delvin, Edgard E ^b  

^a Centre Hospitalier de Sorel   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Congenital hypothyroidism; Thyroid function; Thyrotropin; Thyroxin

Indexed keywords

CELL NUCLEUS RECEPTOR; MONOCARBOXYLATE TRANSPORTER; PROTIRELIN RECEPTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SELENIUM; SELENOPROTEIN; SODIUM; THYROGLOBULIN; THYROID HORMONE; THYROID PEROXIDASE; THYROTROPIN RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CONGENITAL HYPOTHYROIDISM; HORMONE METABOLISM; PRIORITY JOURNAL; THYROID FUNCTION;

EID: 33646772555     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.03.015     Document Type: Article

References (91)

1. Cranefield P.F. The discovery of cretinism. Bull. Hist. Med. 36 (1962) 489-511
2. Hetzel B.S. The story of Iodine deficiency: An international challenge in nutrition (1989), Oxford University Press, Oxford, UK
3. Curling T.B. Two cases of absence of the thyroid body, and symmetrical swellings of tissue at the sides of the neck, connected with defective cerebral development. Med. Chir. Thorac. 33 (1850) 303-306
4. Fagge C.H. On sporadic cretinism occurring in England. Royal Med. Chir. Soc. (London) 54 (1871) 1566-1569
5. Osler W. On sporadic cretinism in America. Trans Congr Am. Phys. Surg. 4 (1897) 169-206
6. Murray G.R. Note on the treatment of myxoedema by hypodermic injection of an extract of the thyroid gland of a sheep. BMJ 2 (1891) 796-797
7. Hutchison R. Preliminary notes on the active substance in the thyroid. BMJ 7 (1896) 722-723
8. Baumann E. Ueber das normale vorkommen von jod im thierkorper. Hoppe-Seyler Z. Physiol. Chem. 21 (1895) 319
9. Chalmers J.R., Dickson G.T., Elks J., and Hems B.A. The synthesis of thyroxine and related substances: V. Part. A synthesis of l-thyroxine from l-tyrosine. J. Chem. Soc. (1949) 3424
10. Andersen H.J. Studies of hypothyroidism in children. Acta Paediatr. Scand. 223 suppl. (1961) 7-150
11. Jackson I.M.D. Inherited hypothyroidism. Clin. Perinatol. 3 (1976) 221-230
12. Konig M.P. Die Kongenitale hypothyreose und der endemische Kretinismus (1968), Springer, Berlin/Heidelberg 17-168
13. Wilson J.M.G., and Jungner G. Principles and practice of screening for disease. World Health Organization, Technical Series, No 401 (1968), Screening for Inborn Errors of Metabolism, Geneva
14. Raiti S., and Newns G.H. Cretinism: early diagnosis and its relation to mental prognosis. Arch. Dis. Child. 46 (1971) 692-694
15. Klein A.H., Meltzer S., and Kenny F.M. Improved prognosis in congenital hypothyroidism treated before age three months. J. Pediatr. 81 (1972) 912-915
16. Klein R.Z. Infantile hypothyroidism then and now: results of neonatal screening. Curr. Probl. Pediatr. 15 (1985) 1-58
17. Money J., Lewis V., Ehrhardt A.A., and Drash P.W. IQ impairment and elevation in endocrine and related cytogenetic disorders. Proc. Annual Meet. Am. Psychopathol. Assoc. 56 (1967) 22-27
18. Money J., Clarke F.C., and Beck J. Congenital hypothyroidism and IQ increase: a quarter century follow-up. J. Pediatr. 93 (1978) 432-434
19. Glorieux J., Dussault J.H., Morissette J., Desjardins M., Letarte J., and Guyda H. Follow-up at ages 5 and 7 years on mental development in children with hypothyroidism detected by Quebec screening program. J. Pediatr. 107 (1985) 913-915
20. Glorieux J., Desjardins M., Letarte J., Morrissette J., and Dussault J.H. Useful parameters to predict the eventual mental outcome of hypothyroid children. Pediatr. Res. 24 (1988) 6-8
21. Dubuis J.M., Glorieux J., Richer F., Deal C.L., Dussault J.H., and Van Vliet G. Outcome of severe congenital hypothyroidism: closing the developmental gap with early high dose of levothroxine treatment. J. Clin. Endocrinol. Metabol. 81 (1996) 222-227
22. Leutwyler K. The price of prevention. Sci. Am. 10 (1995) 122-129
23. Fisher D.A., Dussault J.H., Foley Jr. T.P., Klein A.H., LaFranchi S., Larsen P.R., et al. Screening for congenital hypothyroidism: results of screening one million North American infants. J. Pediatr. 94 (1979) 700-705
24. Targovnik H.M., Frechtel G.D., Mendive F.M., et al. Evidence for the segregation of three different mutated alleles of the thyroglobulin gene in a Brazilian family with congenital goiter and hypothyroidism. Thyroid 8 (1998) 291-297
25. De Vijlder J.J.M. Primary congenital hypothyroidism: defects in iodine pathway. Eur. J. Endocrinol. 149 (2003) 247-256
26. Chopra I.J. A rapid radioimmunoassay for measurement of thyroxine in unextracted serum. J. Clin. Endocrinol. Metabol. 34 (1972) 938-947
27. 4) determination in dried blood by radioimmunoassay: a screening method for neonatal hypothyroidism. Union Med. Can. 102 (1973) 2062-2064
28. Dussault J.H., Coulombe P., Laberge C., et al. Preliminary report on a mass screening program for neonatal hypothyroidism. J. Pediatr. 86 (1975) 670-674
29. Delange F., Camus M., Winkler M., Dodion J., and Ermans A.M. Serum thyrotrophin determination on day 5 of life as screening procedure for congenital hypothyroidism. Arch. Dis. Child. 52 (1977) 89-96
30. Fisher D.A., and Odell W.D. Acute release of thyrotropin in the newborn. J. Clin. Invest. 48 (1969) 1670-1677
31. La Franchi S.H., Hanna C.E., Krainz P.L., et al. Screening for congenital hypothyroidism with collection at two time periods. Pediatrics 76 (1985) 734-740
32. Delange F. Neonatal screening for congenital hypothyroidism: results and perspectives. Horm. Res. 48 (1997) 51-61
33. VanVliet G. Neonatal endocrinopathies: should we change the screening method?. Ital. J. Pediatr. 31 (2005) 209-212
34. Van Vliet G., and Czernichow P. Screening for neonatal endocrinopathies: rationale, methods and results. Semin. Neonatol. 9 (2004) 75-85
35. Carreiro-Lewandowski E. Newborn screening: An overview. Clin. Lab. Sci. 15 (2002) 229-238
36. Van Vliet G. Hypothyroidism in infants and children. In: Braverman L.E., and Utiger R.D. (Eds). The Thyroid: A Fundamental and Clinical Text (2005), Lippincott Williams and Wilkins, New York 1029-1047
37. Dussault J.H., Grenier A., Morissette J., and Mitchell M. Preliminary report on filter paper TSH levels in the first 24 hours of life and the following days in a program screening for congenital hypothyroidism. In: Pass K.A., and Levy H.L. (Eds). Early Hospital Discharge: Impact on Newborn Screening (1995), Council of Regional Networks for Genetic Services Emory University School of Medicine, Atlanta, US 267-269
38. Pass K.A., Lane P.A., Fernhoff P.M., Hinton C.F., Panny S.R., Parks J.S., et al. US newborn screening system guidelines II: follow-up of children, diagnosis, management, and evaluation. Statement of the Council of Regional Networks for Genetic Services (CORN). J Pediatr. 137 (2000) S1-S46
39. Damante G., Tell G., and Di Lauro R. A unique combination of transcription factors controls differentiation of thyroid cells. Prog. Nucl. Acid. Res. Mol. Biol. 66 (2001) 307-356
40. Zannini M., Avantaggiato V., Biffali E., et al. TTF-2, a new forkhead protein shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation. EMBO J. 16 (1997) 3185-3187
41. Parlato R., Rosica A., Rodriguez-Mallon A., et al. An integrated regulatory network controlling survival and migration in thyroid organogenesis. Dev. Biol. 276 (2004) 464-475
42. VanVliet G. Development of the thyroid gland: lessons from congenitally hypothyroid mice and men. Clin. Genet. 63 (2003) 445-455
43. Kimura S., Hira Y., Pineau T., et al. The T/Erp null-mouse: Thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev. 10 (1996) 60-69
44. Sussel L., Marin O., Kimura S., and Rubenstein J.L. Loss of Nkx2.1 homeobox gene function results in a ventral to dorsal molecular respecification within the basal telencephalon: evidence for a transformation of the pallidum into the striatum. Development 126 (1999) 3359-3370
45. Damante G., and DiLauro R. Thyroid specific gene expression. Biochim. Biophys. Acta 1218 (1994) 255-266
46. Devriendt K., Vanhole C., Matthijs G., and de Zegher F. Deletion of thyroid transcription factor-1 gene in an infant with neonatal thyroid dysfunction and respiratory failure. N. Engl. J. Med. 338 (1998) 1317-1318
47. Iwatani N., Mabe H., Devriendt K., Kodama M., and Miike T. Deletion of NKX2.1 gene encoding thyroid transcription factor-1 in two siblings with hypothyroidism and respiratory failure. J. Pediatr. 137 (2000) 272-276
48. Willemsen A.A.P., Breedveld G.J., Wouda S., et al. Brain-thyroid-lung syndrome: a patient with severe multi-system disorder due to a de novo mutation in the thyroid transcription factor 1 gene. Eur. J. Pediatr. 164 (2005) 28-30
49. Krude H., Schütz B., Biebermann H., et al. Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency. J. Clin. Invest. 109 (2002) 475-480
50. Moeller L.C., Kimura S., Kusakabe T., Liao X.-H., Van Sande J., and Refetoff S. Hypothyroidism in thyroid transcription factor 1 haploinsufficiency is caused by reduced expression of the thyroid-stimulating hormone receptor. Mol. Endocrinol. 17 (2003) 2295-2302
51. Clifton-Bligh R.J., Wentworth J.M., and Heinz P. Mutation in the gene encoding human TTF-2 associated with thyroid agenesis, cleft-palate and choanal atresia. Nat. Genet. 19 (1998) 399-401
52. Castanet M., Park S.M., Smith A., et al. A novel loss-of-function mutation in TTF-2 is associated with congenital hypothyroidism, thyroid agenesis and cleft palate. Hum. Mol. Genet. 11 (2002) 2051-2059
53. Macchia P.A., Lapi P., Krude H., et al. PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis. Nat. Genet. 19 (1998) 83-86
54. de Sanctis L., Corrias A., and Romagnolo D. Familial PAX8 small deletion (c.989_992delACCC) associated with extreme phenotype variability. J. Clin. Endocrinol. Metabol. 89 (2004) 5669-7564
55. Abramowicz M.J., Duprez L., Parma J., Vassart G., and Heinrichs C. Familial congenital hypothyroidism due to an inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland. J. Clin. Invest. 99 (1997) 3018-3024
56. Clifton-Bligh R.J., Gregory J.W., Ludgate M., et al. Two novel mutations in the thyrotropin (TSH) receptor gene in a child with resistance to TSH. J. Clin. Endocrinol. Metabol. 82 (1997) 1094-1100
57. Jordan N., Williams N., Gregory J.W., Evans C., Owen M., and Ludgate M. The W546X mutation of the thyrotropin receptor gene: potential major contributor to thyroid dysfunction in a Caucasian population. J. Clin. Endocrinol. Metabol. 88 (2003) 1002-1005
58. Van de Graaf S.A., Ris-Stalpers C., Pauws E., Mendive F.M., Targovnik H.M., and de Vijlder J.J. Up to date with human thyroglobulin. J. Endocrinol. 170 (2001) 307-321
59. Ieiri T., Cochaux P., Targovnik H.M., et al. A 3'splice site mutation in the thyroglobulin gene responsible for congenital goiter with hypothyroidism. J. Clin. Invest. 88 (1991) 1901-1905
60. Vono-Toniolo J., and Kopp P. Thyroglobulin gene mutations and other genetic defects associated with congenital hypothyroidism. Arq. Bras. Endocrinol. Metabol. 48 (2004) 70-82
61. Taurog A. Hormone synthesis: thyroid iodine metabolism. In: Braverman L.E., and Utiger R.D. (Eds). Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text. 8th ed. (2000), Lippincott-Williams and Wilkins, Philadelphia, PN 61-84
62. Manglabruks A., Correa-Billerbeck A.E., Wajchenberg B., et al. Genetic linkage studies of thyroid peroxidase (TPO) gene in families with TPO deficiency. J. Clin. Endocrinol. Metabol. 72 (1991) 471-476
63. Abramowicz M.J., Targovnik H.M., Varela V., et al. Identification of a mutation in the coding sequence of the human thyroid peroxidase gene causing congenital goiter. J. Clin. Invest. 90 (1992) 1200-1204
64. Bakker B., Bikker H., Vulsma T., de Ramie J.S., Wiedijk B.M., De Vijlder J.J., et al. Two decades of screening for congenital hypothyroidism in The Netherlands: TPO gene mutations in total iodide organification defects (an update). J. Clin. Endocrinol. Metabol. 85 (2000) 3708-3712
65. Dohan O., and Carrasco N. Advances in Na(+)/I (-) symporter (NIS) research in the thyroid and beyond. Mol. Cell. Endocrinol. 213 (2003) 59-70
66. Dohan O., De la Vieja A., Paroder V., et al. The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance. Endocr. Rev. 24 (2003) 48-77
67. Kosugi S., Inoue S., Matsuda A., and Jhiang S.M. Novel, missense and loss-of-function mutations in the sodium/iodide symporter gene causing iodide transport defect in three Japanese patients. J. Clin. Endocrinol. Metabol. 83 (1998) 3373-3376
68. Pohlenz J., Rosenthal I.M., Weiss R.E., Jhiang S.M., Burant C., and Refetoff S. Congenital hypothyroidism due to mutations in the sodium/iodide symporter. Identification of a nonsense mutation producing a downstream cryptic 3' splice site. J. Clin. Invest. 101 (1998) 1028-1035
69. 2-generating system modulates protein iodination and the activity of the pentose phosphate pathway in the dog. Endocrinology 128 (1991) 779-785
70. De Deken X., Wang D., Many M.C., Costagliola S., Libert F., Vassart G., et al. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J. Biol. Chem. 275 30 (2000) 23227-23233 Jul 28
71. 2-generating activity. J. Clin. Endocrinol. Metabol. 86 (2001) 4843-4848
72. Moreno J.C., Bikker H., Kempers M.J.E., et al. Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N. Engl. J. Med. 347 (2002) 95-102
73. Berry M.J., Banu L., and Larsen P.R. Type 1 iodothyronine deiodinase is a seleno-cysteine-containing enzyme. Nature 349 (1991) 438-440
74. Cenas N., Prast S., Nivinskas H., Sarlauskas J., and Arner E.S. Interactions of nitroaromatic compounds with the mammalian selenoprotein thioredoxin reductase and the relation to induction of apoptosis in human cancer cells. J. Biol. Chem. 281 9 (2006) 5593-5603 Mar 3
75. Rundlof A.K., and Arner E.S. Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events. Antioxid. Redox Signal. 6 (2004) 41-52
76. Behne D., and Kyriakopoulos A. Mammalian selenium-containing proteins. Annu. Rev. Nutr. 21 (2001) 453-473
77. Goto C., Osaka T., and Mizutani T. A model for Sec incorporation with the regions upstream of the UGA Sec codon to play a key role. Biofactors 14 (2001) 25-35
78. Mizutani T., and Fujiwara T. SBP, SECIS binding protein, binds to the RNA fragment upstream of the Sec UGA codon in glutathione peroxidase mRNA. Mol. Biol. Rep. 27 (2000) 99-105
79. Berry M.J. Insights into the hierarchy of selenium incorporation. Nat. Genet. 11 (2005) 1162-1163
80. Dumitrescu A.M., Liao X.-H., Abdullah M.S., et al. Mutations in SECISBP2 result in abnormal thyroid hormone synthesis. Nat. Genet. 11 (2005) 1247-1252
81. Friesema E.C., Ganguly A., Abdalla A., Manning J., Fox E., Halestrap A.P., et al. Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J. Biol. Chem. 278 (2003) 40128-40135
82. Dumitrescu A.M., Liao X.H., Best T.B., Brockmann K., and Refetoff S. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am. J. Hum. Genet. 74 (2004) 168-175
83. Weinberger C., Thompson C.C., Ong E.S., Lebo R., Gruol D.J., and Evans R.M. The c-erb-A gene encodes a thyroid hormone receptor. Nature 324 (1986) 641-646
84. Mangelsdorf D.J., Thummel C., Beato M., et al. The nuclear receptor superfamily: the second decade. Cell 83 (1995) 835-839
85. Refetoff S. Resistance to thyroid hormone with and without receptor gene mutations. Ann. Endocrinol. (Paris). 64 (2003) 23-25
86. Fraichard A., Chassande O., Plateroti M., et al. The T3R alpha gene encoding a thyroid hormone receptor is essential for post-natal development and thyroid hormone production. EMBO J. 16 (1997) 4412-4420
87. Collu R., Tang J., Castagné J., et al. A novel mechanism for isolated central hypothyroidism: Inactivating mutations in the thyrotropin-releasing hormone receptor gene. J. Clin. Endocrinol. Metabol. 82 (1997) 1361-1365
88. Hayashizaki Y., Hiraoka Y., Tatsunin K., et al. Deoxyribonucleic acid analysis of five families with familial inherited thyroid stimulating hormone deficiency. J. Clin. Endocrinol. Metabol. 71 (1990) 792-796
89. Dacou-Voutetakis C., Feltquate D.M., Drakopoulou M., Kourides I.A., and Dracopoli N.C. Familial hypothyroidism caused by a nonsense mutation in the thyroid-stimulating hormone beta-subunit gene. Am. J. Hum. Genet. 46 (1990) 988-993
90. Djemli A., Fillion M., Belgoudi J., et al. Twenty years later: a reevaluation of the contribution of plasma thyroglobulin to the diagnosis of thyroid dysgenesis in infants with congenital hypothyroidism. Clin. Biochem. 37 9 (2004) 818-822 Sep
91. Hanukoglu A., Perlman K., Shamis I., et al. Relationship of etiology to treatment in congenital hypothyroidism. J. Clin. Endocrinol. Metab. 86 1 (2001) 186-191